Posttreatment Lyme disease syndrome and myalgic encephalomyelitis/chronic fatigue syndrome: A systematic review and comparison of pathogenesis
Open Access
- 11 June 2023
- journal article
- review article
- Published by Wiley in Chronic Diseases and Translational Medicine
- Vol. 9 (3) , 183-190
Abstract
Lyme disease is the most common vector‐borne illness in the United States and has been causing significant morbidity since its discovery in 1977. It is well‐documented that about 10% of patients properly treated with antibiotics never fully recover, but instead go on to develop a chronic illness dubbed, posttreatment Lyme disease syndrome (PTLDS) characterized by severe fatigue, cognitive slowing, chronic pain, and sleep difficulties. This review includes 18 studies that detail the symptoms of patients with PTLDS and uses qualitative analysis to compare them to myalgic encephalitis/chronic fatigue syndrome (ME/CFS), a strikingly similar syndrome. In the majority of the PTLDS studies, at least four of the six major symptoms of ME/CFS were also noted, including substantial impairment in activity level and fatigue for more than 6 months, post‐exertional malaise, and unrefreshing sleep. In one of the included PTLDS articles, 26 of the 29 ME/CFS symptoms were noted. This study adds to the expanding literature on the post‐active phase of infection syndromes, which suggests that chronic illnesses such as PTLDS and ME/CFS have similar pathogenesis despite different infectious origins.Keywords
This publication has 35 references indexed in Scilit:
- CCL19 as a Chemokine Risk Factor for Posttreatment Lyme Disease Syndrome: a Prospective Clinical Cohort StudyClinical and Vaccine Immunology, 2016
- Randomized Trial of Longer-Term Therapy for Symptoms Attributed to Lyme DiseaseNew England Journal of Medicine, 2016
- Long-term Follow-up of Patients With Lyme Disease: Longitudinal Analysis of Clinical and Quality-of-life MeasuresClinical Infectious Diseases, 2016
- Long-term Assessment of Post-Treatment Symptoms in Patients With Culture-Confirmed Early Lyme DiseaseClinical Infectious Diseases, 2015
- Elevated Levels of IL-23 in a Subset of Patients With Post-Lyme Disease Symptoms Following Erythema MigransClinical Infectious Diseases, 2013
- Anti-neural antibody reactivity in patients with a history of Lyme borreliosis and persistent symptomsBrain, Behavior, and Immunity, 2010
- CCR 7 Ligands Are Required for Development of Experimental Autoimmune Encephalomyelitis through Generating IL-23-Dependent Th17 CellsThe Journal of Immunology, 2009
- Antibiotic-refractory Lyme arthritis is associated with HLA-DR molecules that bind aBorrelia burgdorferipeptideJournal of Experimental Medicine, 2006
- Study and treatment of post Lyme disease (STOP-LD)Neurology, 2003
- Two Controlled Trials of Antibiotic Treatment in Patients with Persistent Symptoms and a History of Lyme DiseaseNew England Journal of Medicine, 2001